INTERPHEX Week Japan 2019 - a leading pharma industry event

INTERPHEX Week Japan is a Asia’s leading exhibition specialised in pharma, cosmetics & bio technologies and grand conference is concurrently held with the exhibition. Below is the show facts of the 2019 edition.

– 4 Specialised Shows within INTERPHEX Week Japan –

More Details

Exhibitor List
Conference Program
Photo Highlight
Floor Map
Media Partners

Concurrent Show

Regenerative Medicine Expo TOKYO

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Continuous Manufacturing is Improving Biopharma Production

AI in Drug Commercialization Market to Grow CAGR 24% by 2032

Continuous Bioprocessing Market to Surge by 2028

Advancing Asia-Pacific Healthcare & Biopharma Innovation

Generative AI in Pharma: Opportunities & Challenges

Global Biopharma Market to Hit $566B by 2032

AI Boosts Small Molecule Therapies for I&I Diseases

Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement with LINDIS Biotech for the Commercial Supply of Catumaxomab

Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront

Continuous Manufacturing is Improving Biopharma Production

AI in Drug Commercialization Market to Grow CAGR 24% by 2032

Continuous Bioprocessing Market to Surge by 2028

Advancing Asia-Pacific Healthcare & Biopharma Innovation

Generative AI in Pharma: Opportunities & Challenges

Global Biopharma Market to Hit $566B by 2032

AI Boosts Small Molecule Therapies for I&I Diseases

Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement with LINDIS Biotech for the Commercial Supply of Catumaxomab

Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront

INTERPHEX Week Japan 2019 – a leading pharma industry event

CURE Pharmaceutical Secures Patent on Oral Thin Films With Bi-Phasic Release of Natural Ingredients

WuXi STA Shanghai & Changzhou Facilities Pass U.S. FDA Inspections

Related Posts

Thermo Fisher to acquire Solventum’s Purification & Filtration business for US$4.1bn

Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement with LINDIS Biotech for the Commercial Supply of Catumaxomab

Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront

Saudi Arabia Poised to Expand Domestic Manufacturing Eco-system as 30,000 Attendees join Inaugural CPHI Middle East

Pharma Contract Manufacturing 2025

Asahi Kasei Microdevices Advances AgeTech with Better AI-Ready Data Through New Sensor Technologies – Devices will be demonstrated at CES 2025, showing how aging in place can be safer and more accessible

WuXi STA Shanghai & Changzhou Facilities Pass U.S. FDA Inspections

Qucik Links

About Us

Subscribe Us

System

Resources

Retrieve your password